Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy-Reference-Cited by-同舟云学术

Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy

Published:2020-08 Issue: Volume:149 Page:30-37
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Cecchin Erika,De Mattia Elena,Dreussi Eva,Montico Marcella^ORCID,Palazzari Elisa,Navarria Federico,Bergamo Francesca,Belluco Claudio,Quartuccio Luca,De Vita Salvatore,Canzonieri Vincenzo,Gagno Sara^ORCID,Zanusso Chiara,Buonadonna Angela,Pucciarelli Salvatore,De Paoli Antonino,Toffoli Giuseppe

Funder

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference49 articles.

1. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors;Liu;J Hematol Oncol,2018

2. Abscopal effect, from myth to reality: from radiation oncologists' perspective;Yilmaz;Cureus,2019

3. Radiotherapy and immunotherapy: a synergistic effect in cancer care;Turgeon;Med J Aust,2019

4. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy;Chen;J Cancer Res Clin Oncol,2019

5. Chemoradiation-Induced alteration of programmed death-ligand 1 and CD8(+) tumor-infiltrating lymphocytes identified patients with poor prognosis in rectal cancer: a matched comparison analysis;Lim;Int J Radiat Oncol Biol Phys,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variable roles of interleukin-17F in different cancers;BMC Cancer;2022-01-11

2. SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy;Frontiers in Pharmacology;2021-12-24

3. Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy;Frontiers in Pharmacology;2020-06-17

4. 3.0 T MRI IVIM-DWI for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer;Abdominal Radiology;2020-05-27